VLA-4 antagonists

Details for Australian Patent Application No. 2006236895 (hide)

Owner Merck & Co., Inc.

Inventors Munoz, Benito; Smith, Nicholas D.; Stock, Nicholas S.

Agent Spruson & Ferguson

Pub. Number AU-A-2006236895

PCT Pub. Number WO2006/113199

Priority 60/671,352 14.04.05 US

Filing date 10 April 2006

Wipo publication date 26 October 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113199 Priority application(s): WO2006/113199

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236899-Supplied air respirator that has an adjustable length hose

2006236894-Methods of enhancing isolation of RNA from biological samples